Azomethine ylide cycloaddition: a versatile tool for preparing novel pyrrolizidino-spiro-oxindolo hybrids of the doubly conjugated alkamide piperine

  • Meenakshi Singh
  • A. V. Amrutha Krishnan
  • Ramkrishna Mandal
  • Jayanta Samanta
  • V. Ravichandiran
  • Ramalingam Natarajan
  • Yogesh P. BharitkarEmail author
  • Abhijit HazraEmail author
Original Article


A facile, multicomponent (MCR) atom-economic synthesis of novel spiro-oxindolo pyrrolizidine adducts of piperine has been achieved via an intermolecular 1,3-dipolar azomethine ylide cycloaddition reaction. Either of the two conjugated double bonds in piperine takes part in the reaction to produce two regioisomeric adducts in racemic form. Acenaphthoquinone, ninhydrin and different isatin derivatives were reacted with proline and piperine to afford a never before reported library of 22 compounds. The structures of the products were determined by 1D/2D NMR, mass spectral analysis and confirmed by X-ray crystallography of selected products. Chiral HPLC separation was performed to measure the specific rotation and CD spectra of the enantiomers for two racemic compounds.

Graphic abstract


Piperine Azomethine ylide cycloaddition Spiro-oxindolo pyrrolizidine Chiral HPLC 



A.H and B.Y. are recipients of Research Fellowships in the form of Young Scientist Grant (YSS/2015/001141) and NPDF/2016/000088 from SERB-DST, India. M.S., A.K. and R.M. thank DOP, Ministry of Chemical and Fertilizers, Govt. of India, for providing fellowship. We also thank R. Gajbhiye of NIPER for his assistance in acquiring HRMS spectra and YMC India Pvt. Ltd for providing CHIRAL Cellulose-C column. Our thanks are due to Director NIPER and IICB for giving laboratory and instrumental facility, and to Drs. N.B. Mondal and B. Achari (Ex-Emeritus Scientist, CSIR-IICB) for helpful suggestions.

Supplementary material

11030_2019_9969_MOESM1_ESM.pdf (23.8 mb)
Supplementary material 1 (PDF 24409 kb)
11030_2019_9969_MOESM2_ESM.pdf (272 kb)
Supplementary material 2 (PDF 271 kb)


  1. 1.
    Tietze LF, Bell HP, Chandrasekhar S (2003) Natural product hybrids as new leads for drug discovery. Angew Chem Int Ed 42:3996–4028. CrossRefGoogle Scholar
  2. 2.
    Guo Z (2017) The modification of natural products for medical use. Acta Pharm Sin B 7(2):119–136. CrossRefGoogle Scholar
  3. 3.
    Clarke SJ, Rivory LP (1999) Clinical pharmacokinetics of docetaxel. Clin Pharmacokinet 36:99–114. CrossRefGoogle Scholar
  4. 4.
    Holton RA, Biediger RJ, Boatman PD (1995) In: Suffness M (ed) Taxol: science and applications. CRC Press Inc, Boca Raton, pp 97–121Google Scholar
  5. 5.
    Bunnag D, Karbwang J, Harinasuta T (1992) Artemether in the treatment of multiple drug resistant falciparum malaria. Southeast Asean J Trop Med Public Health 23:762–767Google Scholar
  6. 6.
    Esu E, Effa EE, Opie ON, Uwaoma A, Meremikwu MM (2014) Artemether for severe malaria. Cochrane Database Syst Rev 9:1–83. Google Scholar
  7. 7.
    CDC-Centers for Disease Control and Prevention (2016) CDC- Malaria-Diagnosis & Treatment (United States)-Treatment (U.S)-Artesunate. Archived from the original on 29 Oct 2016. Retrieved 28 Oct 2016
  8. 8.
    Rosenthal PJ (2008) Artesunate for the treatment of severe falciparum malaria. N Engl J Med 358:1829–1836. CrossRefGoogle Scholar
  9. 9.
  10. 10.
    Lee FYF, Borzilleri R, Fairchild CR, Kamath A, Smykla R, Kramer R, Vite G (2008) Preclinical discovery of ixabepilone, a highly active antineoplastic agent. Cancer Chemother Pharmacol 63:157–166. CrossRefGoogle Scholar
  11. 11.
    Golomb BA (2008) Acetylcholinesterase inhibitors and Gulf War illnesses. Proc Natl Acad Sci 105:4295–4300. CrossRefGoogle Scholar
  12. 12.
    Kingston DGI (2009) Tubulin-interactive natural products as anticancer agents (1). J Nat Prod 72:507–515. CrossRefGoogle Scholar
  13. 13.
    Baell J, Walters MA (2014) Chemistry: chemical con artists foil drug discovery. Nature 513:481–483. CrossRefGoogle Scholar
  14. 14.
    Dahlin JL, Nissink JWM, Strasser JM, Francis S, Higgins L, Zhou H, Zhang Z, Walters MA (2015) PAINS in the assay: chemical mechanisms of assay interference and promiscuous enzymatic inhibition observed during a sulfhydryl-scavenging HTS. J Med Chem 58:2091–2113. CrossRefGoogle Scholar
  15. 15.
    Amslinger S (2010) The tunable functionality of α, β-unsaturated carbonyl compounds enables their differential application in biological systems. Chem Med Chem 5:351–356. CrossRefGoogle Scholar
  16. 16.
    Pavlovska TL, Redkin RG, Lipson VV, Atamanuk DV (2016) Molecular diversity of spirooxindoles. Synthesis and biological activity. Mol Divers 20:299–344. CrossRefGoogle Scholar
  17. 17.
    Jossang A, Jossang P, Hadi HA, Sevenet T, Bodo B (1991) Horsfiline, an oxindole alkaloid from Horsfieldia superba. J Org Chem 56:6527–6530. CrossRefGoogle Scholar
  18. 18.
    Borthwick AD (2012) 2,5-Diketopiperazines: synthesis, reactions, medicinal chemistry, and bioactive natural products. Chem Rev 112:3641–3716. CrossRefGoogle Scholar
  19. 19.
    Miyake FY, Yakushijin K, Horne DA (2004) Preparation and synthetic applications of 2-halotryptamines: synthesis of elacomine and isoelacomine. Org Lett 6:711–713. CrossRefGoogle Scholar
  20. 20.
    Millemaggi A, Taylor RJK (2010) 3-Alkenyl-oxindoles: natural products, pharmaceuticals, and recent synthetic advances in tandem/telescoped approaches. Eur J Org Chem 24:4527–4547. CrossRefGoogle Scholar
  21. 21.
    Galliford CV, Scheidt KA (2007) Pyrrolidinyl-spirooxindole natural products as inspirations for the development of potential therapeutic agents. Angew Chem Int Ed 46:8748–8758. CrossRefGoogle Scholar
  22. 22.
    Thangamani A (2010) Regiospecific synthesis and biological evaluation of spirooxindolopyrrolizidines via [3 + 2] cycloaddition of azomethine ylide. Eur J Med Chem 45:6120–6126. CrossRefGoogle Scholar
  23. 23.
    Liu J, Sun Y, Zhang X, Liang X, Wu Y, Wang Y, Jiang X (2014) Spirooxindoles, a potential novel class of anti-inflammatory agents. Inflamm Cell Signal 1:372. Google Scholar
  24. 24.
    Sun Y, Liu J, Sun T, Zhang X, Yao J, Kai M, Jiang X, Wang R (2014) Anti-cancer small molecule JP-8g exhibits potent in vivo anti-inflammatory activity. Sci Rep 4:4372. CrossRefGoogle Scholar
  25. 25.
    Okita T, Isobe M (1994) Synthesis of the pentacyclic intermediate for dynemicin a and unusual formation of spiro-oxindole ring. Tetrahedron 50:11143–11152. CrossRefGoogle Scholar
  26. 26.
    Rosenmond P, Hosseini Merescht M, Bub C (1994) A simple entry into the series of tetracyclic hetero and secoyohimbanes, strychnos and oxindole alkaloids. Liebigs Ann Chem 2:151–158. CrossRefGoogle Scholar
  27. 27.
    Kornet MJ, Thio AP (1976) Oxindole-3-spiropyrrolidines and -piperidines. Synthesis and local anesthetic activity. J Med Chem 19:892–898. CrossRefGoogle Scholar
  28. 28.
    Jiang H, Zhao J, Han X, Zhu S (2006) Stereoselective preparation of 1,2,4-oxadiazole derivatives substituted by pentafluorophenyl by 1,3-dipolar cycloaddition reaction. Tetrahedron 62:11008–11011. CrossRefGoogle Scholar
  29. 29.
    Coutouli AE, Lianis P, Mitakou M, Giannoulis A, Nowak J (2006) 1,3-Dipolar cycloaddition approach to isoxazole, isoxazoline and isoxazolidine analogues of C-nucleosides related to pseudouridine. Tetrahedron 62:1494–1501. CrossRefGoogle Scholar
  30. 30.
    Gomes PJS, Nunes CM, Pais AACC, Pinho e Melo TMVD, Arnaut LG (2006) 1,3-Dipolar cycloaddition of azomethine ylides generated from aziridines in supercritical carbon dioxide. Tetrahedron Lett. 47:5475–5479. CrossRefGoogle Scholar
  31. 31.
    Abou-Gharbia MA, Doukas PH (1979) Synthesis of tricyclic arylspiro compounds as potential antileukemic and anticonvulsant agents. Heterocycles 12:637–640. CrossRefGoogle Scholar
  32. 32.
    Lundahl K, Schut J, Schlatmann JLMA, Paerels GB, Peters A (1972) Synthesis and antiviral activities of adamantane spiro compounds. 1. Adamantane and analogous spiro-3′-pyrrolidines. J Med Chem 15:129–132. CrossRefGoogle Scholar
  33. 33.
    Kaur A, Singh B, Vyas B, Silakari O (2014) Synthesis and biological activity of 4-aryl-3-benzoyl-5-phenylspiro[pyrrolidine-2.3′-indolin]-2′-one derivatives as novel potent inhibitors of advanced glycation end product. Eur J Med Chem 79:282–289. CrossRefGoogle Scholar
  34. 34.
    Ali MA, Ismail R, Choon TS, Yoon YK, Wei AC, Pandian S, Kumar RS, Osman H, Manogaran E (2010) Substituted spiro [2.3′] oxindolespiro [3.2″]-5,6-dimethoxy-indane-1″-one-pyrrolidine analogue as inhibitors of acetylcholinesterase. Bioorg Med Chem Lett 20:7064–7066. CrossRefGoogle Scholar
  35. 35.
    Ali MA, Ismail R, Choon TS, Kumar RS, Osman H, Arumugam N, Almansour AI, Elumalai K, Singh A (2012) A regio- and stereo-selective 1,3-dipolar cycloaddition for the synthesis of novel substituted 5,6-dimethoxyspiro[5.3′]-oxindole-spiro-[6.3″]-2,3-dihydro-1H-inden-1″-one-7-(substituted aryl)-tetrahydro-1H-pyrrolo[1,2-c][1,3] thiazole. AChE Inhibitor Bioorg Med Chem Lett 22:508–511. CrossRefGoogle Scholar
  36. 36.
    Kumar RR, Perumal S, Senthilkumar P, Yogeeswari P, Sriram D (2008) Discovery of antimycobacterial spiro-piperidin-4-ones: an atom economic, stereoselective synthesis, and biological intervention. J Med Chem 51:5731–5735. CrossRefGoogle Scholar
  37. 37.
    He J, Ouyang G, Yuan Z, Tong R, Shi J, Ouyang L (2013) A facile synthesis of functionalized dispirooxindole derivatives via a three-component 1,3-dipolar cycloaddition reaction. Molecules 18:5142–5154. CrossRefGoogle Scholar
  38. 38.
    Döndas HA, Retamosa MG, Sansano JM (2017) Current trends towards the synthesis of bioactive heterocycles and natural products using 1,3-dipolar cycloadditions (1,3-DC) with azomethine ylides. Synthesis 49:2819–2851. CrossRefGoogle Scholar
  39. 39.
    Kennedy JP, Williams L, Bridges TM, Daniels RN, Weaver D, Lindsley CW (2008) Application of combinatorial chemistry science on modern drug discovery. J Comb Chem 10:345–354. CrossRefGoogle Scholar
  40. 40.
    Hazra A, Paira P, Sahu KB, Naskar S, Saha P, Paira R, Mondal S, Maity A, Luger P, Weber M, Mondal NB, Banerjee S (2010) Chemistry of andrographolide: formation of novel di-spiropyrrolidino and di-spiropyrrolizidino-oxindole adducts via one-pot three-component [3 + 2] azomethine ylide cycloaddition. Tetrahedron Lett 51:1585–1588. CrossRefGoogle Scholar
  41. 41.
    Hazra A, Bharitkar YP, Chakraborty D, Mondal SK, Singal N, Mondal S, Maity A, Paira R, Banerjee S, Mondal NB (2013) Regio- and stereoselective synthesis of a library of bioactive dispiro-oxindolo/acenaphthoquino andrographolides via 1,3-dipolar cycloaddition reaction under microwave irradiation. ACS Comb Sci 15:41–48. CrossRefGoogle Scholar
  42. 42.
    Bharitkar YP, Kanhar S, Suneel N, Mondal SK, Hazra A, Mondal NB (2015) Chemistry of withaferin-A: chemo, regio, and stereoselective synthesis of novel spiro-pyrrolizidino-oxindole adducts of withaferin-A via one-pot three-component [3 + 2] azomethine ylide cycloaddition and their cytotoxicity evaluation. Mol Divers 19:251–261. CrossRefGoogle Scholar
  43. 43.
    Bharitkar YP, Das M, Kumari N, Kumari MP, Hazra A, Bhayye S, Natarajan R, Shah S, Chatterjee S, Mondal NB (2015) Synthesis of bis-pyrrolizidine-fused dispiro-oxindole analogues of curcumin via one-pot azomethine ylide cycloaddition: experimental and computational approach toward regio- and diastereoselection. Org Lett 17:4440–4443. CrossRefGoogle Scholar
  44. 44.
    Singh M, Hazra A, Bharitkar YP, Kalia R, Sahoo A, Saha S, Ravichandiran V, Ghosh S, Mondal NB (2018) Synthesis of diversely substituted bis-pyrrolizidino/thiopyrrolizidino oxindolo/acenaphthyleno curcuminoids via sequential azomethine ylide cycloaddition. RSC Adv 8:18938–18951. CrossRefGoogle Scholar
  45. 45.
    Dey SK, Bose D, Hazra A, Naskar S, Nandy A, Munda RN, Das S, Chatterjee N, Mondal NB, Banerjee S, Saha KD (2013) Cytotoxic activity and apoptosis-inducing potential of di-spiropyrrolidino and di-spiropyrrolizidino oxindole andrographolide derivatives. PLoS ONE 8(3):e58055. CrossRefGoogle Scholar
  46. 46.
    Chakraborty D, Maity A, Jain CK, Hazra A, Bharitkar YP, Jha T, Majumder HK, Roychoudhury S, Mondal NB (2015) Cytotoxic potential of dispirooxindolo/acenaphthoquino andrographolide derivatives against MCF-7 cell line. MedChemComm 6:702–707. CrossRefGoogle Scholar
  47. 47.
    Hazra A, Mondal C, Chakraborty D, Halder AK, Bharitkar YP, Mondal SK, Banerjee S, Jha T, Mondal NB (2015) Towards the development of anticancer drugs from andrographolide: semisynthesis, bioevaluation, QSAR analysis and pharmacokinetic studies. Curr Top Med Chem 15:1013–1026. CrossRefGoogle Scholar
  48. 48.
    Bharitkar YP, Datta S, Sett S, Marathee N, Khan P, Hazra A, Singh M, Sahoo A, Ghosh S, Mondal S, Mitra AK, Ravichandiran V, Mondal NB (2017) In vitro antimicrobial, antiproliferative, and antioxidant activities of bis pyrrolizidine fused dispiro oxindolo curcuminoids. Chem Biol Interface 7(1):19–31Google Scholar
  49. 49.
    Epstein WW, Netz DF, Seidel JL (1993) Isolation of piperine from black pepper. J Chem Educ 70(7):598. CrossRefGoogle Scholar
  50. 50.
    Bang JS, Oh DH, Choi HM, Sur BJ, Lim SJ, Kim JY, Yang HI, Yoo MC, Hahm DH, Kim KS (2009) Anti-inflammatory and antiarthritic effects of piperine in human interleukin 1beta-stimulated fibroblast-like synoviocytes and in rat arthritis models. Arthritis Res Ther 11:R49. CrossRefGoogle Scholar
  51. 51.
    Wattanathorn J, Chonpathompikunlert P, Muchimapura S, Priprem A, Tankamnerdthai O (2008) Piperine, the potential functional food for mood and cognitive disorders. Food Chem Toxicol 46:3106–3110. CrossRefGoogle Scholar
  52. 52.
    Taqvi SI, Shah AJ, Gilani AH (2008) Blood pressure lowering and vasomodulator effects of piperine. J Cardiovasc Pharmacol 52:452–458. CrossRefGoogle Scholar
  53. 53.
    Manayi A, Nabavi SM, Setzer WN, Jafari S (2018) Piperine as a potential anti-cancer agent: a review on preclinical studies. Curr Med Chem 25:4918–4928. CrossRefGoogle Scholar
  54. 54.
    Pathak N, Khandelwal S (2007) Cytoprotective and immunomodulating properties of piperine on murine splenocytes: an in vitro study. Eur J Pharmacol 576:160–170. CrossRefGoogle Scholar
  55. 55.
    Sharma S, Kalia NP, Suden P, Chauhan PS, Kumar M, Ram AB, Khajuria A, Bani S, Khan IA (2014) Protective efficacy of piperine against Mycobacterium tuberculosis. Tuberculosis 94:389–396. CrossRefGoogle Scholar
  56. 56.
    Singh IP, Choudhary A (2015) Piperine and derivatives: trends in structure-activity relationships. Curr Top Med Chem 15:1722–1734. CrossRefGoogle Scholar
  57. 57.
    Qu H, Lv M, Xu H (2015) Piperine: bioactivities and structural modifications. Mini-Rev Med Chem 15:145–156. CrossRefGoogle Scholar
  58. 58.
    Yasir A, Ishtiaq S, Jahangir M, Ajaib M, Salar U, Khan KM (2018) Biology-oriented synthesis (BIOS) of piperine derivatives and their comparative analgesic and antiinflammatory activities. Med Chem 14:269–280. CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.National Institute of Pharmaceutical Education and Research (NIPER), Chunilal BhawanKolkataIndia
  2. 2.Department of Organic and Medicinal ChemistryIndian Institute of Chemical Biology, Council of Scientific and Industrial ResearchKolkataIndia

Personalised recommendations